Catalysts for $INCY
9 tracked
Oct 27, 2026
earnings
INCYTE CORP earnings
INCYTE CORP
→
Jul 28, 2026
earnings
INCYTE CORP earnings
INCYTE CORP
→
Apr 29, 2026
phase 3 initiation
Incyte Corp — retifanlimab (Phase III Trial Initiation)
retifanlimab
→
Apr 28, 2026
earnings
INCYTE CORP earnings
INCYTE CORP
→
Mar 30, 2026
approval
ZYNYZ (RETIFANLIMAB-DLWR) — FDA approval
retifanlimab
→
Dec 17, 2025
approval
ZYNYZ (RETIFANLIMAB-DLWR) — FDA approval
retifanlimab
→
May 15, 2025
approval
ZYNYZ (RETIFANLIMAB-DLWR) — FDA approval
retifanlimab
→
Apr 22, 2024
approval
ZYNYZ (RETIFANLIMAB-DLWR) — FDA approval
retifanlimab
→
Mar 22, 2023
approval
ZYNYZ (RETIFANLIMAB-DLWR) — FDA approval
retifanlimab
→